Charles River Laboratories (CRL) reported fourth quarter adjusted EPS of $0.69 after the close Monday, compared to $0.60 in the prior year. The consensus estimate was for EPS of $0.56. Full year 2012 adjusted EPS is expected to come in between $2.60 and $2.70. The consensus estimate is for EPS of $2.64. The stock is now up 1.15 on 8K shares.
Charles River Laboratories gapped up slightly Monday, but traded in a range throughout the session. Shares finished up by 0.13 at $33.90.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.